The role of interleukin 10 in allergic inflammation;Rola interleukiny 10 w zapaleniu alergicznym

Polski Merkuriusz Lekarski

Volumn 18, Issue 104, 2005, Pages 125-128

  Tworek, Damian ^a   Kuna, Piotr ^a  

^a Medical University of Lodz Klinika Pneumonologii i Alergologii   (Poland)

Author keywords

Inflammation; Interleukin 10 (IL 10)

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 10 RECEPTOR;

ALLERGY; ANTIBODY PRODUCTION; ANTIINFLAMMATORY ACTIVITY; CLONAL ANERGY; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; DRUG EFFECT; INFLAMMATION; REVIEW; T LYMPHOCYTE ACTIVATION;

B-LYMPHOCYTES; DESENSITIZATION, IMMUNOLOGIC; HUMANS; HYPERSENSITIVITY; IMMUNOLOGIC FACTORS; INFLAMMATION; INTERLEUKIN-10; RECEPTORS, INTERLEUKIN-10; T-LYMPHOCYTES; TH2 CELLS;

EID: 14644415896     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (79)

1. Akbari O., de Kruyff R.H., Umetsu D.T.: Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen. Nat. Immunol., 2001, 2 (8), 725.
2. Akdis C.A. i wsp.: Rote of interleukin 10 in specific immunotherapy. J. Clin. Invest., 1998, 102 (1), 98.
3. Akdis C.A. i wsp.: A molecular basis for T cell suppression by IL-10, CD28-associated IL-10 receptor inhibits CD28 tyrosine phosphorylation and phosphatidylinositol 3-kinase binding. FASEB J., 2000, 14 (12), 1666.
4. Arock M. i wsp.: Interleukin-10 inhibits cytokine generation from mast cells. Eur. J. Immunol., 1996, 26 (1), 166.
5. Barnes P.J.: IL-10, a key regulator of allergic disease. Clin. Exp. Allergy, 2001, 31 (5), 667.
6. Becker J.C. i wsp.: Negative transcriptional regulation in anergic T cells. Proc. Natl. Acad. Sci., USA, 1995, 92 (6), 2375.
7. Berkman N. i wsp.: Inhibition of macrophage inflammatory protein-1α expression by IL-10. Differential sensitivities in human blood monocytes and alveolar macrophages. J. Immunol., 1995, 155 (9), 4412.
8. Bofield T.L. i wsp.: Normal bronchial epithelial cells constitutively produce the anti-inflammatory cytokine interleukin-10, which is downregulated in cystic fibrosis. Am. J. Respir. Cell. Mol. Biol., 1995, 13 (3), 257.
9. Bogdan C., Vodovotz Y., Nathan C.: Macrophage deactivation by interleukin 10. J. Exp. Med., 1991, 174 (6), 1549.
10. Borish L.: IL-10, evolving concepts. J. Allergy Clin. Immunol., 1998, 101 (3), 293-297.
11. Borish L. i wsp.: Interleukin-10 regulation in normal subjects and patients with asthma. J. Allergy Clin. Immunol., 1996, 97 (6), 1288.
12. Chen W.F., Zlotnik A.: IL-10, a novel cytotoxic T cell differentiation factor. J. Immunol., 1991, 147 (2), 528.
13. Chung K.F. i wsp.: Induction of eotaxin expression and release from human airway smooth muscle cells by IL-1β and TNF-α, effects of IL-10 and corticosteroids. Br. J. Pharmacol., 1999, 127 (5), 1145.
14. Colavita A.M. i wsp.: Kinetics of IL-10 production after segmental antigen chellenge of atopic asthmatic subjects. J. Allergy Clin. Immunol., 2000, 106 (5), 88.
15. Crepaldi L. i wsp.: Molecular basis of the synergistic production of IL-1 receptor antagonist by human neuthrophils stimulated with IL-4 and IL-10. Int. Immunol., 2002, 14 (10), 1145.
16. D'Andrea A.i wsp.: Interleukin 10 (IL-10) inhibits human lymphocyte interferon-γ production by suppressing natural killer cell stimulatory factor/ IL-12 synthesis in accessory cells. J. Exp. Med., 1993, 178 (3), 1041.
17. Defrance T. i wsp.: Interleukin 10 and transforming growth factor beta cooperate to induce anti-CD40-activated naive human B cells to secrete immunoglobulin A. J. Exp. Med., 1992, 175 (3), 671.
18. Del Prete G. i wsp.: Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. J. Immunol., 1993, 150 (2), 353.
19. Ding L., Shevach E.M.: IL-10 inhibits mitogen-induced T cell proliferation by selectively inhibiting macrophage costimulatory function. J. Immunol., 1992, 148 (10), 3133.
20. Ding L. i wsp.: IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression. J. Immunol., 1993, 151 (3), 1224.
21. Ding Y. i wsp.: Differential IL-10R1 expression plays a critical role in IL-10-mediated immune regulation. J. Immunol., 2001, 167 (12), 6884.
22. Enk A.H., Katz S.I.: Identification and induction of keratinocyte-derived IL-10. J. Immunol., 1992, 149 (1), 92.
23. Enk A.H. i wsp.: Inhibition of Langerhans cell antigen-presenting function by IL-10. A role for IL-10 in induction of tolerance. J. Immunol., 1993, 151 (5), 2390.
24. Eskdale J. i wsp.: Microsatellite alleles and single nucleotide polymorphisms (SNP) combine to form four major haplotype families at the human interleukin-10 (IL-10) locus. Genes Immun., 1999, 1 (2), 151.
25. Fields P.E., Gajewski T.F., Fitch F.W.: Blocked Ras activation in anergic CD4+ T cells. Science, 1996, 271 (5253), 1276.
26. Finbloom D.S., Winestock K.D.: IL-10 induces the tyrosine phosphorylation of tyk2 and Jak1 and the differential assembly of STAT1 alpha and STAT3 complexes in human T cells and monocytes. J. Immunol., 1995, 155 (3), 1079.
27. Fiorentino D.F., Bond M.W., Mosmann T.R.: Two types of mouse T helper cell.IV.Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J. Exp. Med., 1989, 170 (6), 2081.
28. Fiorentine D.F. i wsp.: IL-10 inhibits cytokine production by activated macrophages. J. Immunol., 1991, 147 (11), 3815.
29. Gaglani B. i wsp.: Nasal immunotherapy in weed-induced allergic rhinitis. Ann. Allergy Asthma Immunol., 1997, 79 (3), 259.
30. Go N.F. i wsp.: Interleukin 10, a novel B cell stimulatory factor, unresponsiveness of X chromosome-linked immunodeficiency B cells. J. Exp. Med., 1990, 172 (6), 1625.
31. Grünig G. i wsp.: Interleukin-10 is a natural suppressor of cytokine production and inflammation in a murine model of allergic bronchopulmonary aspergillosis. J. Exp. Med., 1997, 185 (6), 1089.
32. Grunstein M.M. i wsp.: Autocrine signaling by IL-10 mediates altered responsiveness of atopic sensitized airway smooth muscle. Am. J. Physiol. Lung Cell Mol. Physiol. 2001, 281 (5), L1130.
33. Ho A.S. i wsp.: Functional regions of the mouse interleukin-10 receptor cytoplasmic domain. Mol. Cell. Biol., 1995, 15 (9), 5045.
34. Hsu D.-H., Moore K.W.: Spits H., Differential effects of interleukin-4 and -10 on interleukin-2 induced interferon-γ synthesis and lymphokine-activated killer activity. Int. Immunol., 1992, 4 (5), 563.
35. Immunologia. Red. Goła̧b J., Jakóbisiak M., Lasek W. Wyd. Naukowe PWN, Warszawa, 2002.
36. Ippoliti F. i wsp.: Effect of preseasonal enzyme potentiated desensitisation (EPD) on plasma-IL-6 and IL-10 of grass pollen-sensitive asthmatic children. Allerg. Immunol. (Paris), 1997, 29 (5), 123.
37. Ishizuka T. i wsp.: Interleukin-10 is localized to and released by human lung mast cells. Clin. Exp. Allergy, 1999, 29 (10), 1424.
38. 4 production can be differentially regulated by IL-10. J. Immunol., 1998, 160 (7), 3555.
39. John M. i wsp.: Inhaled corticosteroids increase interleukin-10 but reduce macrophage inflammatory protein-1α, granulocyte-macrophage colony-stimulating factor, and interferon-γ release from alveolar macrophages in asthma. Am. J. Respir. Crit. Care Med., 1998, 157 (1), 256.
40. Josephson K. i wsp.: Design and analysis of an engineered human interleukin-10 monomer. J. Biol. Chem., 2000, 275 (32), 13552.
41. Joss A. wsp.: IL-10 directly acts on T cells by specifically altering the CD28 co-stimulation pathway. Eur. J. Immunol., 2000, 30 (6), 1683.
42. Kang S.M. wsp.: Transactivation by AP-1 is a molecular target of T cell clonal anergy. Science, 1992, 257 (5073), 1134.
43. Kline J.N. i wsp.: Regulation of interleukin-1 receptor antagonist by Th1 and Th2 cytokines. Am. J. Physiol., 1995, 269 (1 Pt 1), L92.
44. Kotenko S.V. i wsp.: Identification and functional characterization of a second chain of the interleukin-10 receptor complex. EMBO J., 1997, 16 (19), 5894.
45. Li W. i wsp.: Blocked signal transduction to the ERK and JNK protein. Kinases in anergic CD4+ T cells. Science, 1996, 271 (5253), 1272.
46. Lim S. i wsp.: Increased interleukin-10 and macrophage inflammatory protein-1α release from blood monocytes ex vivo during late-phase response to allergen in asthma. Allergy, 2000, 55 (5), 489.
47. Liu Y. i wsp.: Expression cloning and characterization of a human IL-10 receptor. J. Immunol., 1994, 152 (4), 1821.
48. Macatonia S.E. i wsp.: Differential effect of IL-10 on dendritic cell-induced T cell proliferation and IFN-γ production. J. Immunol., 1993, 150 (9), 3755.
49. Malisan F. i wsp.: Interleukin-10 induces immunoglobulin G isotype switch recombination in human CD40-activated naive B lymphocytes. J. Exp. Med., 1996, 183 (3), 937.
50. Mascali J.J. i wsp.: Anti-inflammatory effects of theophylline, modulation of cytokine production. Ann. Allergy Asthma Immunol., 1996, 77 (1), 34.
51. Marshall J.S. i wsp.: Interleukin (IL)-10 inhibits long-term IL-6 production but not preformed mediator release from rat peritoneal mast cells. J. Clin. Invest., 1996, 97 (4), 1122.
52. Mäkelä M.J. i wsp.: IL-10 is necessary for the expression of airway hyperresponsiveness but not pulmonary inflammation after allergic sensitization. Proc. Natl. Acad. Sci., USA, 2000, 97 (11), 6007.
53. Niiro H. i wsp.: Regulation by interleukin-10 and interleukin-4 of cyclooxygenase-2 expression in human neutrophils. Blood, 1997, 89 (5), 1621.
54. Niiro H. i wsp.: Inhibition by interleukin-10 of inducible cyclooxygenase expression in lipopolysaccharide-stimulated monocytes, its underlaying mechanism in comparison with interleukin-4. Blood, 1995, 85 (12), 3736.
55. O'Farell A.-M. i wsp.: IL-10 inhibits macrophage activation and proliferation by distinct signaling mechanisms, evidence for Stat3-dependent and -independent pathways. EMBO J., 1998, 17 (4), 1006.
56. Ohkawara Y. i wsp.: CD40 expression by human peripheral blood eosinophils. J. Clin. Invest., 1996, 97 (7), 1761.
57. Oliver B. i wsp.: Low-dose theophylline does not exert its anti-inflammatory effects in mild asthma through upregulation of interleukin-10 in alveolar macrophages. Allergy, 2001, 56 (11), 1087.
58. Punnonen J. i wsp.: IL-10 and viral IL-10 prevent IL-4- induced IgE synthesis by inhibiting the accessory cell function of monocytes. J. Immunol., 1993, 151 (3), 1280.
59. Ralph P. i wsp.: IL-10, T lymphocyte inhibitor of human blood cell production of IL-1 and tumor necrosis factor. J. Immunol., 1992, 148 (3), 808.
60. Riley J.K. i wsp.: Interleukin-10 receptor signaling through the JAK-STAT pathway. J. Biol. Chem., 1999, 274 (23), 16513.
61. Royer B. i wsp.: Inhibition of IgE-induced activation of human mast cells by IL-10. Clin. Exp. Allergy, 2001, 31 (5), 694.
62. Schwartz R.H.: Models of T cell anergy, is there a common molecular mechanism? J. Exp. Med., 1996, 184 (1), 1.
63. Stämpfli M.R. i wsp.: Interleukin-10 gene transfer to the airway regulates allergic mucosal sensitization in mice. Am. J. Respir. Cell Mol. Biol., 1999, 21 (5), 586.
64. Stelmach I. i wsp.: Stȩżenie IL-10 w surowicy dzieci chorych na astmȩ oskrzelowa̧. Pneumonol. Alergol. Pol., 2002, 70 (1-2), 25.
65. Stelmach I., Jerzyńska J., Kuna P.: A randomized, double-blind trial of the effect of glucocorticoid, antileukotriene and β-agonist on IL-10 serum levels in children with astma. Clin. Exp. Allergy, 2002, 32 (2), 264.
66. Suberville S. i wsp.: Regulation of interleukin-10 production by β-adrenergic agonists. Eur. J. Immunol., 1996, 26 (11), 2601.
67. Takanasaki S. i wsp.: Interleukin 10 inhibits lipopolysaccharide-induced survival and cytokine production by human peripheral blood eosinophils. J. Exp. Med., 1994, 180 (2), 711.
68. Thompson-Snipes L. i wsp.: Interleukin 10, a novel stimulatory factor for mast cells and their progenitors. J. Exp. Med., 1999, 173 (2), 507.
69. Vieira P. i wsp.: Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones, Homology to Epstein-Barr virus open reading frame BCRFI. Proc. Natl. Acad. Sci., USA, 1991, 88 (4), 1172.
70. de Waal Malefyt R. i wsp.: Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J. Exp. Med., 1991, 174 (4), 915.
71. de Waal Malefyt R. i wsp.: Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes, an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med., 1991, 174 (5), 1209.
72. Walter M.R., Nagabhushan T.L.: Crystal structure of interleukin 10 reveals an interferon gamma-like fold. Biochemistry, 1995, 34 (38), 12118.
73. Wanidworanun C., Srober W.: Predominant role of tumor necrosis factor-α in human monocyte IL-10 synthesis. J. Immunol., 1993, 151 (12), 6853.
74. Weber-Nordt R.M. i wsp.: Stat3 recruitment by two distinct ligand-induced, tyrosine-phosphorylated docking sites in the interleukin-10 receptor intracellular domain. J. Biol. Chem., 1996, 271 (44), 27954.
75. Wehinger J. i wsp.: IL-10 induces DNA binding activity of three STAT proteins (Stat1, Stat3 amd Stat5) and their distinct combinatorial assembly in the promoters of selected genes. FEBS Lett., 1996, 394 (3), 365.
76. Williams TM. wsp.: Identification of a zinc finger protein that inhibits IL-2 gene expression. Science, 1991, 254 (5039), 1791.
77. Yasui D.H. i wsp.: Transcriptional repression of the IL-2 gene in Th cells by ZEB. J. Immunol., 1998, 160 (9), 4433.
78. Zemann B. i wsp.: Oral administration of specific antigens to allergy-prone infant dogs induces IL-10 and TGF-β expression and prevents allergy in adult life. J. Allergy Clin. Immunol., 2003, 111 (5), 1069.
79. Zuzany-Amorim C. i wsp.: Interleukin-10 inhibits antigen-induced cellular recruitment into the airways of sensitized mice. J. Clin. Invest., 1995, 95 (6), 2644.